KITE-439

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KITE-439, covering 2023-12-26 to 2023-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers [Phase 1]

See pricing